The estimated Net Worth of Mark Sabag is at least $15.9 million dollars as of 5 March 2024. Mr. Sabag owns over 100,000 units of Teva- Pharmaceutical Industries stock worth over $6,871,316 and over the last 7 years he sold TEVA stock worth over $3,818,916. In addition, he makes $5,245,340 as Executive Vice President et Chief Human Resources Officer and Global Communications and Brand at Teva- Pharmaceutical Industries.
Mark has made over 17 trades of the Teva- Pharmaceutical Industries stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 100,000 units of TEVA stock worth $1,352,000 on 5 March 2024.
The largest trade he's ever made was selling 127,244 units of Teva- Pharmaceutical Industries stock on 16 March 2021 worth over $1,427,678. On average, Mark trades about 30,312 units every 88 days since 2018. As of 5 March 2024 he still owns at least 382,590 units of Teva- Pharmaceutical Industries stock.
You can see the complete history of Mr. Sabag stock trades at the bottom of the page.
Mark Sabag serves as Executive Vice President, Chief Human Resources Officer and Global Communications and Brand of the Company. He assumed the role of Executive Vice President, Chief Human Resources Officer and Global Communications and Brand. From 2013 to November 2017, he served as Group Executive Vice President, Human Resources. From 2012 to 2013, Mr. Sabag served as Global Deputy Vice President, Human Resources. From 2010 to 2012, he served as Vice President, Human Resources for Teva’s International Group. From 2006 to 2010, he served as Vice President, Human Resources International Group and Corporate Human Capital. Prior to joining Teva, Mr. Sabag held senior human resources roles with Intel Corporation. Mr. Sabag received a B.A. in economics and business management from Haifa University.
As the Executive Vice President et Chief Human Resources Officer and Global Communications and Brand of Teva- Pharmaceutical Industries, the total compensation of Mark Sabag at Teva- Pharmaceutical Industries is $5,245,340. There are 2 executives at Teva- Pharmaceutical Industries getting paid more, with Kaare Schultz having the highest compensation of $11,596,600.
Mark Sabag is 49, he's been the Executive Vice President et Chief Human Resources Officer and Global Communications and Brand of Teva- Pharmaceutical Industries since 2019. There are 24 older and 5 younger executives at Teva- Pharmaceutical Industries. The oldest executive at Teva- Pharmaceutical Industries Ltd. is Gerald Lieberman, 73, who is the Independent Director.
Mark's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, L3, 6944020.
Over the last 7 years, insiders at Teva- Pharmaceutical Industries have traded over $31,332,399 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 . The most active insiders traders include Sol J Barer, Tal Zvi Zaks et Roberto Mignone. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 9 days with the average trade being worth of $636,538. The most recent stock trade was executed by Varda Shalev on 2 September 2024, trading 12,872 units of TEVA stock currently worth $231,181.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: